Detection and quantitation of HCV RNA using real-time PCR after automated sample processing

Journal of Medical Virology

Volumn 79, Issue 12, 2007, Pages 1821-1826

  Sandres Saune K ^a,b,d   Abravanel, F ^a,b   Nicot, F ^a,b   Peron, J M ^c   Alric, L ^c   Boineau, J ^b   Pasquier, C ^a,b   Izopet, J ^a,b  

^a INSERM   (France)

^b Institut Federatif de Biologie   (France)

^c CHU PURPAN   (France)

^d TSA 40031   (France)

Author keywords

Automated extraction; COBAS Ampliprep; COBAS Taqman; HCV RNA quantitation; Hepatitis C virus

Indexed keywords

PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

ANALYZER; ARTICLE; ASSAY; DIAGNOSTIC KIT; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INSTRUMENTATION; INTERMETHOD COMPARISON; NONHUMAN; PHYLOGENETIC TREE; PROGNOSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS HEPATITIS;

AUTOMATION; GENOTYPE; HEPACIVIRUS; HUMANS; LINEAR MODELS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

HEPATITIS C VIRUS;

EID: 35548933202     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21003     Document Type: Article

References (26)

1. Barbeau JM, Goforth J, Caliendo AM, Nolte FS. 2004. Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent. J Clin Microbiol 42:3739-3746.
2. Fried MW. 2004. Viral factors affecting the outcome of therapy for chronic hepatitis C. Rev Gastroenterol Disord 4:S8-S13.
3. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL, Jr., Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347:975-982.
4. Gelderblom HC, Menting S, Beld MG. 2006. Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum. Antivir Ther 11:95-103.
5. Gerken G, Rothaar T, Rumi MG, Soffredini R, Trippler M, Blunk MJ, Butcher A, Soviero S, Colucci G. 2000. Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination. J Clin Microbiol 38:2210-2214.
6. Germer JJ, Harmsen WS, Mandrekar JN, Mitchell PS, Yao JD. 2005. Evaluation of the COBAS TaqMan HCV test with automated sample processing using the MagNA pure LC instrument. J Clin Microbiol 43:293-298.
7. Gourlain K, Soulier A, Pellegrin B, Bouvier-Alias M, Hezode C, Darthuy F, Remire J, Pawlotsky JM. 2005. Dynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay. J Clin Microbiol 43:1669-1673.
8. Hadziyannis SJ, Sette H, Jr., Morgan TR, Balan V, Diago M, Marcellin P, Ramadori G, Bodenheimer H, Jr., Bernstein D, Rizzetto M, Zeuzem S, Pockros PJ, Lin A, Ackrill AM. 2004. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose. Ann Intern Med 140:346-355.
9. Halfon P, Bourliere M, Penaranda G, Khiri H, Ouzan D. 2006. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J Clin Microbiol 44:2507-2511.
10. Izopet J, Payen JL, Alric L, Sandres K, Charlet JP, Vinel JP, Duffaut M, Pascal JP, Puel J. 1998. Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy. J Med Virol 54:86-91.
11. Konnick EQ, Williams SM, Ashwood ER, Hillyard DR. 2005. Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan analyte-specific reagent assay and comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 assays. J Clin Microbiol 43:2133-2140.
12. Lee SC, Antony A, Lee N, Leibow J, Yang JQ, Soviero S, Gutekunst K, Rosenstraus M. 2000. Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: Calibration to international units, enhanced genotype reactivity, and performance characteristics. J Clin Microbiol 38:4171-4419.
13. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 358:958-965.
14. Martinot-Peignoux M, Marcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, Benhamou J, Erlinger S. 1995. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatits C. Hepatology 22:1050-1056.
15. Mellor J, Hawkins A, Simmonds P. 1999. Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J Clin Microbiol 37:2525-2532.
16. Michelin BD, Muller Z, Stelzl E, Marth E, Kessler HH. 2007. Evaluation of the Abbott RealTime HCV assay for quantitative detection of hepatitis C virus RNA. J Clin Virol 38:96-100.
17. Pawlotsky JM. 2002. Use and interpretation of virological tests for hepatitis C. Hepatology 36:S65-S73.
18. Roque Afonso AM, Didier J, Plouvier E, Falissard B, Ferey MP, Bogard M, Dussaix E. 2000. Performance of an automated system for quantification of hepatitis C virus RNA. J Virol Methods 86:55-60.
19. Sandres-Saune K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J. 2003. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods 109:187-193.
20. Sarrazin C, Hendricks DA, Sedarati F, Zeuzem S. 2001. Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a. J Clin Microbiol 39:2850-2855.
21. Sarrazin C, Gartner BC, Sizmann D, Babiel R, Mihm U, Hofmann WP, von Wagner M, Zeuzem S. 2006. Comparison of conventional PCR with real-time PCR andbranched DNA-based assays for hepatitis C virus RNA quantification and clinical significance for genotypes 1 to 5. J Clin Microbiol 44:729-737.
22. Sizmann D, Boeck C, Boelter J, Fischer D, Miethke M, Nicolaus S, Zadak M, Babiel R. 2007. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS((R)) AmpliPrep/COBAS((R)) TaqMan((R)) System. J Clin Virol 38:326-333.
23. Stelzl E, Kormann-Klement A, Haas J, Daghofer E, Santner BI, Marth E, Kessler HH. 2002. Evaluation of an automated sample preparation protocol for quantitative detection of hepatitis C virus RNA. J Clin Microbiol 40:1447-1450.
24. Trimoulet P, Halfon P, Pohier E, Khiri H, Chene G, Fleury H. 2002. Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum. J Clin Microbiol 40:2031-2036.
25. Trimoulet P, de Ledinghen V, Foucher J, Castera L, Fleury H, Couzigou P. 2004. Predictive value of early HCV RNA quantitation for sustained response in nonresponders receiving daily interferon and ribavirin therapy. J Med Virol 72:46-51.
26. Yu ML, Chuang WL, Dai CY, Chen SC, Lin ZY, Hsieh MY, Wang LY, Chang WY. 2000. Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test. J Clin Microbiol 38:2933-2939.